Annual Results Results Snapshot
Figures in Million
Consolidated - Balance Sheet Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
0.00
0.00
0.00
0.00
0.00
0.00
Share Warrants & Outstandings
Total Reserve
22.85
29.60
36.27
42.81
46.99
51.12
Shareholder's Funds
22.85
29.60
36.27
42.81
46.99
51.12
Minority Interest
-0.31
-0.34
-0.29
-0.21
-0.12
-0.04
Long-Term Borrowings
15.63
13.13
16.37
15.97
16.02
19.42
Secured Loans
15.63
13.13
16.37
15.97
16.02
19.42
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
0.00
0.00
0.00
0.00
0.00
-0.02
Other Long Term Liabilities
11.24
11.75
12.17
7.58
9.58
12.13
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Non-Current Liabilities
21.42
24.53
28.37
22.58
24.58
30.63
Current Liabilities
Trade Payables
13.91
14.04
10.82
9.64
13.40
9.99
Other Current Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Current Liabilities
31.62
27.98
28.58
19.28
25.67
24.15
Total Liabilities
75.58
81.78
92.93
84.46
97.13
105.86
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
8.85
9.28
7.59
5.26
6.16
7.10
Less: Accumulated Depreciation
2.39
2.24
2.09
3.79
3.56
3.39
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
6.45
7.04
5.50
1.47
2.60
3.71
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Advances
0.00
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
13.79
15.50
10.05
12.47
14.89
18.85
Total Non-Current Assets
39.13
46.06
47.05
38.77
47.16
55.70
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
4.00
4.61
9.86
8.43
10.64
8.87
Sundry Debtors
11.70
9.76
13.16
6.88
12.38
7.86
Cash and Bank
17.96
18.32
19.76
27.04
24.75
28.21
Other Current Assets
33.67
32.69
42.79
42.35
47.77
44.94
Short Term Loans and Advances
0.00
0.00
0.00
0.00
0.00
0.00
Total Current Assets
36.45
35.71
45.87
45.69
49.97
50.16
Net Current Assets (Including Current Investments)
4.83
7.73
17.29
26.41
24.30
26.01
Total Current Assets Excluding Current Investments
36.45
35.71
45.87
45.69
49.97
50.16
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
75.58
81.78
92.93
84.46
97.13
105.86
Contingent Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Total Debt
15.63
13.13
16.37
15.97
16.02
19.42
Book Value per share (adjusted)
Balance Sheet Analysis Highlights
Compare Balance Sheet Results of Cumberland Pharmaceuticals, Inc.
Figures in Million
Consolidated - Balance Sheet Results
Change(USD)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
0
0
0.00
0.00%
Share Warrants & Outstandings
Total Reserve
22.85
14.72
8.13
55.23%
Shareholder's Funds
22.85
14.72
8.13
55.23%
Minority Interest
-0.31
0
-0.31
0.00%
Long-Term Borrowings
15.63
0.01
15.62
156,200.00%
Secured Loans
15.63
0.01
15.62
156,200.00%
Unsecured Loans
0
0
0.00
0.00%
Deferred Tax Assets / Liabilities
0
0
0.00
0.00%
Other Long Term Liabilities
11.24
0
11.24
0.00%
Long Term Trade Payables
0
0
0.00
0.00%
Long Term Provisions
0
0
0.00
0.00%
Total Non-Current Liabilities
21.42
0
21.42
0.00%
Current Liabilities
Trade Payables
13.91
2.52
11.39
451.98%
Other Current Liabilities
0
0
0.00
0.00%
Short Term Borrowings
0
0
0.00
0.00%
Short Term Provisions
0
0
0.00
0.00%
Total Current Liabilities
31.62
6.70
24.92
371.94%
Total Liabilities
75.58
21.42
54.16
252.85%
ASSETS
Non-Current Assets
0
0
0.00
0.00%
Gross Block
8.85
0
8.85
0.00%
Less: Accumulated Depreciation
2.39
0
2.39
0.00%
Less : Impairment of Assets
0
0
0.00
0.00%
Net Block
6.45
0.01
6.44
64,400.00%
Lease Adjustment
0
0
0.00
0.00%
Capital Work in Progress
0
0
0.00
0.00%
Intangible assets under development
0
0
0.00
0.00%
Pre-operative Expenses pending
0
0
0.00
0.00%
Assets in transit
0
0
0.00
0.00%
Non Current Investments
0
1.50
-1.50
-100.00%
Long Term Loans & Advances
0
0
0.00
0.00%
Other Non Current Assets
13.79
0
13.79
0.00%
Total Non-Current Assets
39.13
12.01
27.12
225.81%
Current Assets Loans & Advances
Current Investments
0
8.35
-8.35
-100.00%
Inventories
4.00
0
4.00
0.00%
Sundry Debtors
11.70
0
11.70
0.00%
Cash and Bank
17.96
0.17
17.79
10,464.71%
Other Current Assets
33.67
8.52
25.15
295.19%
Short Term Loans and Advances
0
0
0.00
0.00%
Total Current Assets
36.45
9.41
27.04
287.35%
Net Current Assets (Including Current Investments)
4.83
2.71
2.12
78.23%
Total Current Assets Excluding Current Investments
36.45
9.41
27.04
287.35%
Miscellaneous Expenses not written off
0
0
0.00
0.00%
Total Assets
75.58
21.42
54.16
252.85%
Contingent Liabilities
0
0
0.00
0.00%
Total Debt
15.63
0.01
15.62
156,200.00%
Book Value per share (adjusted)
0
0
0.00
0.00%
Annual - Borrowings
Analysis not available as Data has been published for only 1 period
Annual - Other Long Term Liabilities
Analysis not available as Data has been published for only 1 period
Annual - Fixed Assets
Analysis not available as Data has been published for only 1 period
Annual - Investments
Analysis not available as Data has been published for only 1 period
Annual - Current Assets
Analysis not available as Data has been published for only 1 period
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
